Insulin lispro mix 25/75 twice daily (LM25) vs basal insulin glargine once daily and prandial insulin lispro once daily (BP) in type 2 diabetes: insulin intensification

被引：0
|
作者：
Tinahones, F. J. [1 ]
Gross, J. L. [2 ]
Onaca, A.
Zhou, Z. [3 ,4 ]
Cleall, S. [5 ]
Rodriguez, A. [6 ]
机构：
[1] Hosp Univ Virgen de la Victoria, Malaga, Spain
[2] Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil
[3] Second Xiangya Hosp, Ctr Diabet, Inst Metab & Endocrinol, Changsha, Hunan, Peoples R China
[4] Key Lab Diabet Immunol, Changsha, Hunan, Peoples R China
[5] Eli Lilly & Co, Windlesham, Surrey, England
[6] Lilly Spain, Alcobendas, Spain
来源：
DIABETOLOGIA | 2013年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1025
引用
收藏
页码：S412 / S412
页数：1
相关论文
共 50 条
  • [1] INSULIN LISPRO MIX 25/75 TWICE DAILY (LM25 BID) VS BASAL INSULIN GLARGINE plus PRANDIAL INSULIN LISPRO BOTH ONCE DAILY (IGL) IN TYPE 2 DIABETES (T2D): ANALYSIS BASED ON THE MAIN MEAL
    Gross, J. L.
    Rojas, A.
    Shah, S.
    Tinahones, F. J.
    Cleall, S.
    Rodriguez, A.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S115 - S116
  • [2] Insulin lispro low mixture twice daily versus basal insulin glargine once daily and prandial insulin lispro once daily in patients with type 2 diabetes requiring insulin intensification: a randomized phase IV trial
    Tinahones, F. J.
    Gross, J. L.
    Onaca, A.
    Cleall, S.
    Rodriguez, A.
    DIABETES OBESITY & METABOLISM, 2014, 16 (10): : 963 - 970
  • [3] Insulin lispro low mixture twice daily vs basal insulin glargine once daily and prandial insulin lispro once daily as insulin intensification strategies in patients with type 2 diabetes: Latin American subpopulation analysis of a randomized trial
    Arturo Rojas
    Georgina Sposetti
    Jorge L. Gross
    Douglas Eugenio Barbieri
    Ran Duan
    Bruno Linetzky
    Janaina Martins De Lana
    Oded Stempa
    Angel Rodriguez
    Diabetology & Metabolic Syndrome, 8
  • [4] Insulin lispro low mixture twice daily vs basal insulin glargine once daily and prandial insulin lispro once daily as insulin intensification strategies in patients with type 2 diabetes: Latin American subpopulation analysis of a randomized trial
    Rojas, Arturo
    Sposetti, Georgina
    Gross, Jorge L.
    Barbieri, Douglas Eugenio
    Duan, Ran
    Linetzky, Bruno
    De Lana, Janaina Martins
    Stempa, Oded
    Rodriguez, Angel
    DIABETOLOGY & METABOLIC SYNDROME, 2016, 8
  • [5] Insulin lispro low mixture twice daily vs basal insulin glargine once daily and prandial insulin lispro once daily as insulin intensification strategies in patients with type 2 diabetes: A Latin American subpopulation analysis of a randomized trial
    Douglas Eugenio Barbieri
    Ran Duan
    Jorge Gross
    Bruno Linetzky
    Janaina Martins De Lana
    Arturo Rojas
    Georgina Sposetti
    Oded Stempa
    Angel Rodriguez
    Diabetology & Metabolic Syndrome, 7 (Suppl 1):
  • [6] Comparison of insulin intensification strategies with insulin lispro low mixture twice daily versus basal insulin glargine and prandial insulin lispro once daily in East Asian and Caucasian patients with type 2 diabetes mellitus
    Jeong, In-Kyung
    Chung, Choon Hee
    Zhou, Zhiguang
    Han, Jeong Hee
    Duan, Ran
    Edralin, Diana M.
    Rodriguez, Angel
    JOURNAL OF DIABETES, 2017, 9 (04) : 396 - 404
  • [7] Insulin lispro low mixture twice daily versus basal insulin glargine once daily and prandial insulin lispro once daily in patients with type 2 diabetes mellitus requiring insulin intensification—a randomized phase IV trial: Indian subpopulation analyses
    K. M. Prasanna Kumar
    Sanjiv Shah
    Parag Shah
    Simon Cleall
    Steve Chen
    Shweta Uppal
    International Journal of Diabetes in Developing Countries, 2017, 37 : 116 - 123
  • [8] Insulin lispro low mixture twice daily versus basal insulin glargine once daily and prandial insulin lispro once daily in patients with type 2 diabetes mellitus requiring insulin intensification-a randomized phase IV trial: Indian subpopulation analyses
    Prasanna Kumar, K. M.
    Shah, Sanjiv
    Shah, Parag
    Cleall, Simon
    Chen, Steve
    Uppal, Shweta
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2017, 37 (02) : 116 - 123
  • [9] Basal insulin glargine vs prandial insulin lispro in type 2 diabetes
    Arnolds, Sabine
    Rave, Klaus
    LANCET, 2008, 372 (9636): : 370 - 371
  • [10] Basal insulin glargine vs prandial insulin lispro in type 2 diabetes -: Reply
    Linn, Thomas
    Landgraf, W.
    Bretzel, Reinhard G.
    LANCET, 2008, 372 (9636): : 372 - 372
12345